{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:58:34Z","timestamp":1790420314991,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR09-08"],"award-info":[{"award-number":["W.OR09-08"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jneuroim.2015.10.019","type":"journal-article","created":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T14:00:20Z","timestamp":1447250420000},"page":"162-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Elevated plasma inflammatory mediators in post-polio syndrome: No association with long-term functional decline"],"prefix":"10.1016","volume":"289","author":[{"given":"A.","family":"Bickerstaffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1269-0710","authenticated-orcid":false,"given":"A.","family":"Beelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2015.10.019_bb0005","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17a monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Baeten","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cyto.2015.01.008","article-title":"Non-traditional cytokines: how catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system","volume":"72","author":"Barnes","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0015","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.clinph.2013.11.003","article-title":"Loss of motor unit size and quadriceps strength over 10years in post-polio syndrome","volume":"125","author":"Bickerstaffe","year":"2014","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nmd.2014.11.015","article-title":"Change in physical mobility over 10years in postpoliosyndrome","volume":"25","author":"Bickerstaffe","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003747","article-title":"Il-17 attenuates degradation of are-mrnas by changing the cooperation between AU-binding proteins and microRNA16","volume":"9","author":"Chowdhury","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0030","first-page":"241","article-title":"New neuromuscular symptoms after old polio (\u201cthe post-polio syndrome\u201d): clinical studies and pathogenetic mechanisms","volume":"23","author":"Dalakas","year":"1987","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/WNL.38.1.99","article-title":"Morphologic changes in the muscles of patients with postpoliomyelitis neuromuscular symptoms","volume":"38","author":"Dalakas","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-510X(02)00314-3","article-title":"Pro-inflammatory cytokines and motor neuron dysfunction: is there a connection in post-polio syndrome?","volume":"205","author":"Dalakas","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0045","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1056\/NEJM198604103141505","article-title":"A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms","volume":"314","author":"Dalakas","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/mus.20104","article-title":"Motor unit characteristics in healthy subjects and those with postpoliomyelitis syndrome: a high-density surface EMG study","volume":"30","author":"Drost","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1468-1331.2006.01552.x","article-title":"Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study","volume":"14","author":"Farbu","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jns.2008.03.015","article-title":"Elevated serum inflammatory markers in post-poliomyelitis syndrome","volume":"271","author":"Fordyce","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/B:JOCI.0000025450.48267.a5","article-title":"Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients","volume":"24","author":"Frisullo","year":"2004","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archneur.1989.00520410031018","article-title":"T-cell alterations in late postpoliomyelitis","volume":"46","author":"Ginsberg","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0075","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11517-012-1029-y","article-title":"A new and fast approach towards semg decomposition","volume":"51","author":"Gligorijevic","year":"2013","journal-title":"Med. Biol. Eng. Comput."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-510X(02)00316-7","article-title":"Prior poliomyelitis-evidence of cytokine production in the central nervous system","volume":"205","author":"Gonzalez","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jneuroim.2004.01.010","article-title":"Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production","volume":"150","author":"Gonzalez","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0090","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jprot.2008.11.014","article-title":"Identification of novel candidate protein biomarkers for the post-polio syndrome \u2014 implications for diagnosis, neurodegeneration and neuroinflammation","volume":"71","author":"Gonzalez","year":"2009","journal-title":"J. Proteome"},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1742-2094-9-167","article-title":"Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up","volume":"9","author":"Gonzalez","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3928\/0147-7447-19850701-06","article-title":"New problems in old polio patients: results of a survey of 539 polio survivors","volume":"8","author":"Halstead","year":"1985","journal-title":"Orthopedics"},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0105","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1136\/jnnp.74.12.1655","article-title":"Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement","volume":"74","author":"Horemans","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0110","article-title":"Treatment for postpolio syndrome","volume":"5","author":"Koopman","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1600-0765.1991.tb01799.x","article-title":"The regulatory effects of monocytes on human natural killer cells activated by lipopolysaccharides","volume":"26","author":"Lindemann","year":"1991","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0120","series-title":"White Plains. Identifying Best Practices in Diagnosis & Care","article-title":"Post-polio syndrome: identifying best practices in diagnosis & care","author":"March of Dimes","year":"2000"},{"issue":"pt 8","key":"10.1016\/j.jneuroim.2015.10.019_bb0125","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/brain\/120.8.1415","article-title":"Early and late losses of motor units after poliomyelitis","volume":"120","author":"Mccomas","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2340\/16501977-1230","article-title":"Elevated expression of prostaglandin E2 synthetic pathway in skeletal muscle of prior polio patients","volume":"46","author":"Melin","year":"2014","journal-title":"J. Rehabil. Med."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.1995.tb27544.x","article-title":"Post-polio syndrome spinal cord pathology. Case report with immunopathology","volume":"753","author":"Miller","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0003-9993(99)90110-7","article-title":"Disability and functional assessment in former polio patients with and without postpolio syndrome","volume":"80","author":"Nollet","year":"1999","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0145","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/archneur.1988.00520290033010","article-title":"Long-term changes in the spinal cords of patients with old poliomyelitis. Signs of continuous disease activity","volume":"45","author":"Pezeshkpour","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0150","first-page":"668","article-title":"Muscle fiber specific apoptosis and tnf-alpha signaling in sarcopenia are attenuated by life-long calorie restriction","volume":"19","author":"Phillips","year":"2005","journal-title":"Fasten. J."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0155","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/eji.1830260526","article-title":"Dissociation between cytokine mrna expression and protein production in shigellosis","volume":"26","author":"Raqib","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00424-014-1527-x","article-title":"Current understanding of sarcopenia: possible candidates modulating muscle mass","volume":"467","author":"Sakuma","year":"2015","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0165","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/gerona\/glp097","article-title":"Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength","volume":"64","author":"Schaap","year":"2009","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0170","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM199109123251101","article-title":"Intrathecal immune response in patients with the post-polio syndrome","volume":"325","author":"Sharief","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0175","first-page":"265","article-title":"Proinflammatory cytokines and skeletal muscle","volume":"7","author":"Spate","year":"2004","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0180","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2340\/16501977-0188","article-title":"SF36 physical functioning scale and 2-minute walk test advocated as core qualifiers to evaluate physical functioning in patients with late-onset sequelae of poliomyelitis","volume":"40","author":"Stolwijk-Swuste","year":"2008","journal-title":"J. Rehabil. Med."},{"key":"10.1016\/j.jneuroim.2015.10.019_bb0185","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2340\/16501977-0884","article-title":"Effect of intravenous immunoglobulin on pain in patients with post-polio syndrome","volume":"43","author":"Werhagen","year":"2011","journal-title":"J. Rehabil. Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:27:20Z","timestamp":1759048040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572815300643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":37,"alternative-id":["S0165572815300643"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.10.019","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated plasma inflammatory mediators in post-polio syndrome: No association with long-term functional decline","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}